Developer docs
API playgroundTry for free, no card

Search company profiles

Growth Science

Full company profile

uuid00092ny

Namestring
Growth Science
Legal namestring
Growth Science International, LLC
Websiteurl
growthsci.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Growth Science International, LLC (operating as Growth Science Ventures or GS Ventures) is a privately held venture capital firm founded in 2006 and headquartered in Lake Oswego, Oregon. The firm deploys equity capital into early-stage companies operating in complex industries where systemic bottlenecks constrain value creation. Its central offering is not a software product but a proprietary analytical infrastructure—developed over approximately 18 years—that dynamically tracks value chain behavior to identify where constraints accumulate and where capital can produce system-level unlocks. The methodology originated from a collaboration with Clayton Christensen and Intel, and the firm operationalizes it through a three-step protocol: deconstruct the system, identify the bottlenecks, and deploy capital to clear them.\n\nGrowth Science Ventures invests directly into portfolio companies, frequently co-investing with strategic partners—most notably Corteva Catalyst, the investment arm of Corteva Inc. Active portfolio verticals include agritech (Resurrect Bio, IBI Ag, Micropep, Solasta Bio, Puna Bio), diagnostics and health (Viome, Hone Health, Tasso, Firefly Neuroscience, Getlabs), and multi-industry companies (Pyrra Technologies, Golden). The firm cites 60+ research collaborations and analysis of 1,000+ market segments as the empirical foundation underlying its investment approach. Revenue is generated from investment returns—capital gains realized through exits, acquisitions, and public offerings such as Firefly Neuroscience's NASDAQ debut—rather than disclosed management fees or carried interest.\n\nThe firm operates with a small team of 1-10 employees and a global deployment footprint spanning the United States, France, India, and the United Kingdom. With no discrete SaaS products, APIs, or commercial software offerings, the firm monetizes through transaction-based investment outcomes rather than recurring contracts. Leadership comprises CEO Zeke Camusio and Founder Thomas Thurston. Ownership is privately held at the Growth Science International, LLC level with no disclosed parent company, institutional investors, or fund-size transparency; this lack of disclosure limits external visibility into capital base and revenue mechanics.

Short descriptiontext

Growth Science Ventures (GS Ventures) is a privately held venture capital firm deploying equity capital into early-stage companies in complex industries where systemic bottlenecks constrain value, using proprietary dynamic value chain analysis developed over 18 years.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHenderson, United States
HQ citystring
Henderson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital, innovation analytics, investment risk management, equity capital deployment, portfolio diligence
Industry2 codes
PRIMARYFSANACAM
Agriculture & Food / AgTech Growth Equity
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity
NAICS code1 code
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns / Capital Gains
TypeTransaction Fee
Description

Growth Science Ventures generates returns through equity investments in portfolio companies. The firm identifies constrained systems and deploys capital to unlock value, earning returns through exits, acquisitions, and public offerings of portfolio companies.

gsventures.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Growth Science is a venture capital firm that helps executives risk-manage organic innovation, M&A, and venture capital portfolios. The firm identifies bottlenecks in complex industries and deploys capital through equity investments to resolve them, operating a proprietary analytical framework originated in 2006 from a collaboration with Clayton Christensen and Intel. Capital is deployed into agritech, diagnostics, and multi-industry companies, frequently as co-investments alongside strategic partners such as Corteva Catalyst.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Growth Science (also known as Growth Science Ventures or GS Ventures) is a venture capital firm, not a traditional software product company. Its core offering is analytical infrastructure and investment methodology — a systematic approach to finding bottlenecks in complex industries where value accumulates or gets stuck, then deploying capital to resolve those constraints. The firm has spent nearly 18 years building and pressure-testing its analytical methodology through 60+ research collaborations and 1,000+ market segment analyses. There are no discrete software products, SaaS offerings, or modules to enumerate; the company provides investment services and strategic capital deployment across industries including agritech, diagnostics, and multi-industry sectors.

Product and service2 records
1Growth Science Venture Capital Investments
CategoryVenture Capital
Description

Equity capital deployment into agritech, diagnostics, and multi-industry companies that address structural bottlenecks in complex industries, typically executed as direct investments or co-investments alongside strategic partners such as Corteva Catalyst.

2Executive Innovation and M&A Risk Management Advisory
CategoryManagement Consulting
Description

Advisory engagement that helps corporate executives apply the Growth Science framework to risk-manage their organic innovation pipelines, M&A programs, and venture capital portfolios.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large life-sciences VC that originates and builds companies around breakthrough scientific platforms. Comparable in its deep-R&D-driven investment thesis and healthcare/diagnostics focus, though at significantly larger scale.

TypeBroad incumbent
Description

Long-tenured deep-tech and life-sciences VC that funds companies built on complex scientific breakthroughs. Similar in its patience for long-horizon, science-heavy bets including diagnostics and biotech.

3Finistere Ventures
TypeDirect peer
Description

Agritech- and food-tech-focused venture firm investing in crop science, biologicals, and digital agriculture. Direct vertical overlap with Growth Science's agritech portfolio (seed treatments, bio-pesticides).

TypeDirect peer
Description

Mission-driven VC investing in companies addressing systemic 'world-positive' problems across health, food, and sustainability. Comparable in its thesis-driven approach to identifying high-impact investment opportunities in complex systems.

5Leaps by Bayer
TypeBroad incumbent
Description

Bayer's impact-driven investment vehicle backing breakthroughs in health and agriculture. Mirrors the Growth Science-Corteva Catalyst dynamic of a corporate parent co-investing with an independent VC partner.

TypeDirect peer
Description

Deep-tech VC that backs companies applying breakthroughs in materials, biology, and computing to large, hard problems. Comparable investment philosophy of funding bottleneck-resolving science-based companies.

TypeBroad incumbent
Description

Large, science-heavy venture firm investing across technology, sustainability, health, and food/ag. Comparable in its willingness to invest in contrarian, science-based, bottleneck-solving companies at early stages.

TypeDirect peer
Description

Venture firm focused on food, agriculture, and ocean technology, with strategic corporate LPs. Closely comparable to Growth Science's agritech focus and Corteva-style corporate co-investor model.

TypeDirect peer
Description

Science- and technology-focused venture firm that invests in 'counter-conventional' companies tackling hard scientific and engineering bottlenecks. Most comparable to Growth Science's thesis of finding and funding companies that resolve system-level constraints.

TypeBroad incumbent
Description

Patient, science-led venture fund backed by ultra-high-net-worth investors, focused on climate, agriculture, and sustainability. Comparable in its tolerance for long-horizon, science-intensive bets and concentration in sustainability-adjacent verticals.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Growth Science

Venture Capitalgrowthsci.com

Growth Science Ventures (GS Ventures) is a privately held venture capital firm deploying equity capital into early-stage companies in complex industries where systemic bottlenecks constrain value, using proprietary dynamic value chain analysis developed over 18 years.

What Growth Science does

Growth Science International, LLC (operating as Growth Science Ventures or GS Ventures) is a privately held venture capital firm founded in 2006 and headquartered in Lake Oswego, Oregon. The firm deploys equity capital into early-stage companies operating in complex industries where systemic bottlenecks constrain value creation. Its central offering is not a software product but a proprietary analytical infrastructure—developed over approximately 18 years—that dynamically tracks value chain behavior to identify where constraints accumulate and where capital can produce system-level unlocks. The methodology originated from a collaboration with Clayton Christensen and Intel, and the firm operationalizes it through a three-step protocol: deconstruct the system, identify the bottlenecks, and deploy capital to clear them.\n\nGrowth Science Ventures invests directly into portfolio companies, frequently co-investing with strategic partners—most notably Corteva Catalyst, the investment arm of Corteva Inc. Active portfolio verticals include agritech (Resurrect Bio, IBI Ag, Micropep, Solasta Bio, Puna Bio), diagnostics and health (Viome, Hone Health, Tasso, Firefly Neuroscience, Getlabs), and multi-industry companies (Pyrra Technologies, Golden). The firm cites 60+ research collaborations and analysis of 1,000+ market segments as the empirical foundation underlying its investment approach. Revenue is generated from investment returns—capital gains realized through exits, acquisitions, and public offerings such as Firefly Neuroscience's NASDAQ debut—rather than disclosed management fees or carried interest.\n\nThe firm operates with a small team of 1-10 employees and a global deployment footprint spanning the United States, France, India, and the United Kingdom. With no discrete SaaS products, APIs, or commercial software offerings, the firm monetizes through transaction-based investment outcomes rather than recurring contracts. Leadership comprises CEO Zeke Camusio and Founder Thomas Thurston. Ownership is privately held at the Growth Science International, LLC level with no disclosed parent company, institutional investors, or fund-size transparency; this lack of disclosure limits external visibility into capital base and revenue mechanics.

Growth Science firmographics

Firmographics
Name
Growth Science
Legal name
Growth Science International, LLC
Website
https://growthsci.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
1–10 employees
Short description
Growth Science Ventures (GS Ventures) is a privately held venture capital firm deploying equity capital into early-stage companies in complex industries where systemic bottlenecks constrain value, using proprietary dynamic value chain analysis developed over 18 years.
Ownership category
akta.pro rank

Growth Science industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAM
Agriculture & Food / AgTech Growth Equity
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity

Keywords

  • Venture capital
  • Innovation analytics
  • Investment risk management
  • Equity capital deployment
  • Portfolio diligence

Where Growth Science is headquartered

Location

Headquarters

HQ city
Henderson
HQ country
United States
HQ region
North America

Markets served

Growth Science business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Investment Returns / Capital Gains: Growth Science Ventures generates returns through equity investments in portfolio companies. The firm identifies constrained systems and deploys capital to unlock value, earning returns through exits, acquisitions, and public offerings of portfolio companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Growth Science product offering

Product offering

Core offering

Growth Science is a venture capital firm that helps executives risk-manage organic innovation, M&A, and venture capital portfolios. The firm identifies bottlenecks in complex industries and deploys capital through equity investments to resolve them, operating a proprietary analytical framework originated in 2006 from a collaboration with Clayton Christensen and Intel. Capital is deployed into agritech, diagnostics, and multi-industry companies, frequently as co-investments alongside strategic partners such as Corteva Catalyst.

Product overview

Growth Science (also known as Growth Science Ventures or GS Ventures) is a venture capital firm, not a traditional software product company. Its core offering is analytical infrastructure and investment methodology — a systematic approach to finding bottlenecks in complex industries where value accumulates or gets stuck, then deploying capital to resolve those constraints. The firm has spent nearly 18 years building and pressure-testing its analytical methodology through 60+ research collaborations and 1,000+ market segment analyses. There are no discrete software products, SaaS offerings, or modules to enumerate; the company provides investment services and strategic capital deployment across industries including agritech, diagnostics, and multi-industry sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Growth Science Venture Capital Investments Equity capital deployment into agritech, diagnostics, and multi-industry companies that address structural bottlenecks in complex industries, typically executed as direct investments or co-investments alongside strategic partners such as Corteva Catalyst.
  • Executive Innovation and M&A Risk Management Advisory Advisory engagement that helps corporate executives apply the Growth Science framework to risk-manage their organic innovation pipelines, M&A programs, and venture capital portfolios.

Companies that use Growth Science

Customer profile

Segments3 records

Ideal customer profiles2 records

Growth Science technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Growth Science partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Growth Science competitors and assessment

Company assessment

Broad incumbents

  • Flagship Pioneering: Large life-sciences VC that originates and builds companies around breakthrough scientific platforms. Comparable in its deep-R&D-driven investment thesis and healthcare/diagnostics focus, though at significantly larger scale.
  • ARCH Venture Partners: Long-tenured deep-tech and life-sciences VC that funds companies built on complex scientific breakthroughs. Similar in its patience for long-horizon, science-heavy bets including diagnostics and biotech.
  • Leaps by Bayer: Bayer's impact-driven investment vehicle backing breakthroughs in health and agriculture. Mirrors the Growth Science-Corteva Catalyst dynamic of a corporate parent co-investing with an independent VC partner.
  • Khosla Ventures: Large, science-heavy venture firm investing across technology, sustainability, health, and food/ag. Comparable in its willingness to invest in contrarian, science-based, bottleneck-solving companies at early stages.
  • Breakthrough Energy Ventures: Patient, science-led venture fund backed by ultra-high-net-worth investors, focused on climate, agriculture, and sustainability. Comparable in its tolerance for long-horizon, science-intensive bets and concentration in sustainability-adjacent verticals.

Direct peers

  • Finistere Ventures: Agritech- and food-tech-focused venture firm investing in crop science, biologicals, and digital agriculture. Direct vertical overlap with Growth Science's agritech portfolio (seed treatments, bio-pesticides).
  • Obvious Ventures: Mission-driven VC investing in companies addressing systemic 'world-positive' problems across health, food, and sustainability. Comparable in its thesis-driven approach to identifying high-impact investment opportunities in complex systems.
  • DCVC: Deep-tech VC that backs companies applying breakthroughs in materials, biology, and computing to large, hard problems. Comparable investment philosophy of funding bottleneck-resolving science-based companies.
  • S2G Ventures: Venture firm focused on food, agriculture, and ocean technology, with strategic corporate LPs. Closely comparable to Growth Science's agritech focus and Corteva-style corporate co-investor model.
  • Lux Capital: Science- and technology-focused venture firm that invests in 'counter-conventional' companies tackling hard scientific and engineering bottlenecks. Most comparable to Growth Science's thesis of finding and funding companies that resolve system-level constraints.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Growth Science social profiles

Digital presence

Growth Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Growth Science leadership team

Management profile

Number of profiles

Profiles1 record

Growth Science funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Growth Science M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Growth Science

What does Growth Science do?

Growth Science is a venture capital firm that helps executives risk-manage organic innovation, M&A, and venture capital portfolios. The firm identifies bottlenecks in complex industries and deploys capital through equity investments to resolve them, operating a proprietary analytical framework originated in 2006 from a collaboration with Clayton Christensen and Intel. Capital is deployed into agritech, diagnostics, and multi-industry companies, frequently as co-investments alongside strategic partners such as Corteva Catalyst.

Is Growth Science a public or private company?

Growth Science is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Growth Science founded?

Growth Science was founded in 2006. It employs 1 to 10 people.

Where is Growth Science based?

Growth Science is headquartered in Henderson, United States, in the North America region.

How does Growth Science make money?

One revenue line is on record: investment Returns / Capital Gains.

Who are Growth Science's main competitors?

Broad incumbents on record are Flagship Pioneering, ARCH Venture Partners, Leaps by Bayer, Khosla Ventures and Breakthrough Energy Ventures. Direct peers are Finistere Ventures, Obvious Ventures, DCVC, S2G Ventures and Lux Capital.

Does Growth Science have an API?

No public API is recorded for Growth Science.

What industry is Growth Science in?

Growth Science's product category is Venture Capital. Its primary akta.pro industry code is FSANACAM, Agriculture & Food / AgTech Growth Equity, with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals